Prospective randomized trial of the effects of rosuvastatin on the progression of stenosis in adult patients with congenital aortic stenosis.

Trial Profile

Prospective randomized trial of the effects of rosuvastatin on the progression of stenosis in adult patients with congenital aortic stenosis.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 May 2011

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Aortic valve stenosis
  • Focus Therapeutic Use
  • Acronyms PROCAS
  • Most Recent Events

    • 10 May 2011 Results published in the American Journal of Cardiology.
    • 08 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top